123 related articles for article (PubMed ID: 29247659)
1. Variability in the Expression of Immunohistochemical Markers: Implications for Biomarker Interpretation in Cutaneous T-Cell Lymphoma.
Rahbar Z; Li S; Tavallaee M; Novoa RA; Kim J; Kim YH
J Invest Dermatol; 2018 May; 138(5):1204-1206. PubMed ID: 29247659
[No Abstract] [Full Text] [Related]
2. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
Kleinhans M; Tun-Kyi A; Gilliet M; Kadin ME; Dummer R; Burg G; Nestle FO
Blood; 2003 Feb; 101(4):1487-93. PubMed ID: 12393570
[TBL] [Abstract][Full Text] [Related]
3. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
5. CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma.
Prince HM
J Clin Oncol; 2015 Nov; 33(32):3691-6. PubMed ID: 26392103
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
7. Classification of primary cutaneous T-cell lymphomas.
Willemze R; Beljaards RC; Meijer CJ
Histopathology; 1994 May; 24(5):405-15. PubMed ID: 8088712
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.
Mao X; Orchard G; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
J Invest Dermatol; 2006 Jun; 126(6):1388-95. PubMed ID: 16614728
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.
Yagi H; Seo N; Ohshima A; Itoh T; Itoh N; Horibe T; Yoshinari Y; Takigawa M; Hashizume H
Am J Surg Pathol; 2006 Sep; 30(9):1111-9. PubMed ID: 16931956
[TBL] [Abstract][Full Text] [Related]
10. Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome.
Wada DA; Wilcox RA; Harrington SM; Kwon ED; Ansell SM; Comfere NI
Am J Hematol; 2011 Mar; 86(3):325-7. PubMed ID: 21328438
[No Abstract] [Full Text] [Related]
11. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostics of primary cutaneous lymphomas].
Felcht M; Hillen U; Klemke CD
Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of the expression of cell adhesion molecules in cutaneous T-cell lymphomas (mycosis fungoides/Sézary syndrome) and inflammatory skin diseases].
López-Lerma I; Estrach MT
Actas Dermosifiliogr; 2010 Dec; 101(10):866-77. PubMed ID: 21159263
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous γδ T-cell lymphoma following mycosis fungoides.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
Int J Dermatol; 2014 Feb; 53(2):e82-4. PubMed ID: 24444029
[No Abstract] [Full Text] [Related]
15. The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study.
Gru AA; Kim J; Pulitzer M; Guitart J; Battistella M; Wood GS; Cerroni L; Kempf W; Willemze R; Pawade J; Querfeld C; Schaffer A; Pincus L; Tetzlaff M; Duvic M; Scarisbrick J; Porcu P; Mangold AR; DiCaudo DJ; Shinohara M; Hong EK; Horton B; Kim YH
Am J Surg Pathol; 2018 Jun; 42(6):726-734. PubMed ID: 29543675
[TBL] [Abstract][Full Text] [Related]
16. An Elderly Man With New Skin Plaques Consistent With Cutaneous T-Cell Lymphoma.
Rubio-González B; Zain J; Rosen ST; Querfeld C
Oncology (Williston Park); 2016 Oct; 30(10):908-13. PubMed ID: 27744647
[No Abstract] [Full Text] [Related]
17. KIR3DL2 in cutaneous T-cell lymphoma: from a promising biomarker to a potential therapeutic target.
Sun J; Wang Y
Br J Dermatol; 2020 Jun; 182(6):1325-1326. PubMed ID: 31808144
[No Abstract] [Full Text] [Related]
18. CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis.
Sugaya M; Morimura S; Suga H; Kawaguchi M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
J Dermatol; 2015 Jun; 42(6):613-5. PubMed ID: 25809616
[TBL] [Abstract][Full Text] [Related]
19. Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 Motif: Suggestive of Lipid-antigen Selection?
Mantaka P; Malecka A; Trøen G; Helsing P; Gjersvik P; Beiske K; Delabie J
Acta Derm Venereol; 2017 Oct; 97(9):1081-1086. PubMed ID: 28597017
[TBL] [Abstract][Full Text] [Related]
20. Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis.
Behle V; von Braunmühl T; Sayehli C; Gesierich A; Goebeler M; Geissinger E; Wobser M
Acta Derm Venereol; 2017 Aug; 97(8):973-975. PubMed ID: 28512672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
